Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2023-09-11 Purchase |
2023-09-13 06:05 am |
Greenwich LifeSciences Inc. | GLSI | Patel Snehal CEO and CFO 10% Owner |
1,000 | $9.48 | $9,480 | 5,292,177 (Direct) |
View |
| 2023-08-22 Purchase |
2023-08-24 06:05 am |
Greenwich LifeSciences Inc. | GLSI | Patel Snehal CEO and CFO 10% Owner |
1,000 | $9.97 | $9,970 | 5,291,177 (Direct) |
View |
| 2023-08-04 Purchase |
2023-08-08 06:05 am |
Greenwich LifeSciences Inc. | GLSI | Patel Snehal CEO and CFO 10% Owner |
2,000 | $10.55 | $21,100 | 5,290,177 (Direct) |
View |
| 2023-07-21 Purchase |
2023-07-25 06:15 am |
Greenwich LifeSciences Inc. | GLSI | Patel Snehal CEO and CFO 10% Owner |
1,000 | $9.2 | $9,200 | 5,288,177 (Direct) |
View |
| 2023-07-13 Purchase |
2023-07-17 06:15 am |
Greenwich LifeSciences Inc. | GLSI | Thompson Jaye VP Clinical Reg Affairs |
250 | $9.49 | $2,373 | 259,248 (Direct) |
View |
| 2023-05-17 Purchase |
2023-05-18 06:01 am |
Greenwich LifeSciences Inc. | GLSI | Patel Snehal CEO and CFO 10% Owner |
1,000 | $11.69 | $11,690 | 5,287,177 (Direct) |
View |
| 2023-04-28 Purchase |
2023-05-02 06:06 am |
Greenwich LifeSciences Inc. | GLSI | Thompson Jaye VP Clinical Reg Affairs |
250 | $11.22 | $2,805 | 258,998 (Direct) |
View |
| 2023-04-19 Purchase |
2023-04-21 06:05 am |
Greenwich LifeSciences Inc. | GLSI | Patel Snehal CEO and CFO 10% Owner |
7,000 | $11.1 | $77,700 | 5,286,177 (Direct) |
View |
| 2023-04-18 Purchase |
2023-04-20 06:05 am |
Greenwich LifeSciences Inc. | GLSI | Patel Snehal CEO and CFO 10% Owner |
2,000 | $11.12 | $22,240 | 5,279,177 (Direct) |
View |
| 2023-04-11 Purchase |
2023-04-12 06:05 am |
Greenwich LifeSciences Inc. | GLSI | Thompson Jaye VP Clinical Reg Affairs |
1,000 | $11.87 | $11,870 | 258,745 (Direct) |
View |
| 2023-04-11 Purchase |
2023-04-12 06:02 am |
Greenwich LifeSciences Inc. | GLSI | Patel Snehal CEO and CFO 10% Owner |
5,000 | $12.42 | $62,100 | 5,271,177 (Direct) |
View |
| 2023-03-15 Purchase |
2023-03-16 06:05 am |
Greenwich LifeSciences Inc. | GLSI | Thompson Jaye VP Clinical Reg Affairs |
250 | $12.71 | $3,178 | 257,745 (Direct) |
View |
| 2023-03-10 Purchase |
2023-03-13 07:15 am |
Greenwich LifeSciences Inc. | GLSI | Patel Snehal CEO and CFO 10% Owner |
1,000 | $12.12 | $12,120 | 2,737,486 (Direct) |
View |
| 2023-02-24 Purchase |
2023-02-28 06:03 am |
Greenwich LifeSciences Inc. | GLSI | Thompson Jaye VP Clinical Reg Affairs |
250 | $15.39 | $3,849 | 257,495 (Direct) |
View |
| 2023-02-17 Purchase |
2023-02-22 06:07 am |
Greenwich LifeSciences Inc. | GLSI | Patel Snehal CEO and CFO 10% Owner |
600 | $16.53 | $9,918 | 2,736,486 (Direct) |
View |
| 2023-02-10 Purchase |
2023-02-14 06:08 am |
Greenwich LifeSciences Inc. | GLSI | Patel Snehal CEO and CFO 10% Owner |
1,000 | $18.68 | $18,680 | 2,735,886 (Direct) |
View |
| 2023-02-03 Purchase |
2023-02-07 06:10 am |
Greenwich LifeSciences Inc. | GLSI | Thompson Jaye VP Clinical Reg Affairs |
250 | $20.84 | $5,210 | 257,245 (Direct) |
View |
| 2023-01-27 Purchase |
2023-01-31 06:15 am |
Greenwich LifeSciences Inc. | GLSI | Patel Snehal CEO and CFO 10% Owner |
2,000 | $19.35 | $38,700 | 2,734,886 (Direct) |
View |
| 2023-01-27 Purchase |
2023-01-30 06:15 am |
Greenwich LifeSciences Inc. | GLSI | Thompson Jaye VP Clinical Reg Affairs |
250 | $19.2 | $4,800 | 256,995 (Direct) |
View |
| 2023-01-20 Purchase |
2023-01-24 06:05 am |
Greenwich LifeSciences Inc. | GLSI | Patel Snehal CEO and CFO 10% Owner |
1,500 | $17.37 | $26,055 | 2,732,886 (Direct) |
View |
| 2023-01-13 Purchase |
2023-01-17 06:02 am |
Greenwich LifeSciences Inc. | GLSI | Thompson Jaye VP Clinical Reg Affairs |
250 | $16.5 | $4,125 | 256,745 (Direct) |
View |
| 2023-01-06 Purchase |
2023-01-10 06:05 am |
Greenwich LifeSciences Inc. | GLSI | Patel Snehal CEO and CFO 10% Owner |
1,500 | $15.18 | $22,770 | 2,731,386 (Direct) |
View |
| 2022-12-29 Purchase |
2023-01-03 06:05 am |
Greenwich LifeSciences Inc. | GLSI | Patel Snehal CEO and CFO 10% Owner |
4,000 | $15.19 | $60,760 | 2,729,886 (Direct) |
View |
| 2022-12-16 Purchase |
2022-12-20 06:05 am |
Greenwich LifeSciences Inc. | GLSI | Patel Snehal CEO and CFO 10% Owner |
1,000 | $13.01 | $13,010 | 2,725,886 (Direct) |
View |
| 2022-12-16 Purchase |
2022-12-20 06:05 am |
Greenwich LifeSciences Inc. | GLSI | Thompson Jaye VP Clinical Reg Affairs |
250 | $12.94 | $3,235 | 256,495 (Direct) |
View |
| 2022-12-09 Purchase |
2022-12-13 06:05 am |
Greenwich LifeSciences Inc. | GLSI | Patel Snehal CEO and CFO 10% Owner |
2,000 | $13.11 | $26,220 | 2,724,886 (Direct) |
View |
| 2022-12-02 Purchase |
2022-12-06 06:15 am |
Greenwich LifeSciences Inc. | GLSI | Patel Snehal CEO and CFO 10% Owner |
1,000 | $13.84 | $13,840 | 2,722,886 (Direct) |
View |
| 2022-12-02 Purchase |
2022-12-06 06:15 am |
Greenwich LifeSciences Inc. | GLSI | Thompson Jaye VP Clinical Reg Affairs |
250 | $13.98 | $3,495 | 256,245 (Direct) |
View |
| 2022-11-02 Purchase |
2022-11-04 06:15 am |
Greenwich LifeSciences Inc. | GLSI | Patel Snehal CEO and CFO 10% Owner |
2,000 | $8.79 | $17,580 | 2,721,886 (Direct) |
View |
| 2022-10-14 Purchase |
2022-10-17 07:00 am |
Greenwich LifeSciences Inc. | GLSI | Patel Snehal CEO and CFO 10% Owner |
3,000 | $9.75 | $29,250 | 2,719,886 (Direct) |
View |
| 2022-10-07 Purchase |
2022-10-11 06:05 am |
Greenwich LifeSciences Inc. | GLSI | Patel Snehal CEO and CFO 10% Owner |
2,000 | $9.72 | $19,440 | 2,716,886 (Direct) |
View |
| 2022-09-30 Purchase |
2022-10-04 06:05 am |
Greenwich LifeSciences Inc. | GLSI | Patel Snehal CEO and CFO 10% Owner |
1,000 | $9.46 | $9,460 | 2,714,886 (Direct) |
View |
| 2022-09-29 Purchase |
2022-10-03 06:15 am |
Greenwich LifeSciences Inc. | GLSI | Patel Snehal CEO and CFO 10% Owner |
1,000 | $9.23 | $9,230 | 2,713,886 (Direct) |
View |
| 2022-06-24 Purchase |
2022-06-27 06:05 am |
Greenwich LifeSciences Inc. | GLSI | Patel Snehal CEO and CFO 10% Owner |
29,000 | $9.13 | $264,770 | 5,419,307 (Indirect Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2022-06-22 Option Award |
2022-06-24 08:18 am |
N/A 2032-06-22 |
Greenwich LifeSciences Inc. | GLSI | Daugherty Frank Joseph Chief Medical Officer |
104,890 | $0 | 104,890 (Direct) |
View |
| 2022-06-22 Option Award |
2022-06-24 08:16 am |
N/A 2032-06-22 |
Greenwich LifeSciences Inc. | GLSI | Patel Snehal CEO and CFO 10% Owner |
1,073,731 | $0 | 2,122,454 (Direct) |
View |
| 2022-06-22 Option Award |
2022-06-24 08:14 am |
N/A 2032-06-22 |
Greenwich LifeSciences Inc. | GLSI | Thompson Jaye VP Clinical Reg Affairs |
149,818 | $0 | 149,818 (Direct) |
View |
| 2022-06-22 Option Award |
2022-06-24 08:12 am |
N/A 2032-06-22 |
Greenwich LifeSciences Inc. | GLSI | Hallock Kenneth Director |
41,349 | $0 | 41,349 (Direct) |
View |
| 2022-06-22 Option Award |
2022-06-24 08:11 am |
N/A 2032-06-22 |
Greenwich LifeSciences Inc. | GLSI | Rothe Eric Director |
41,349 | $0 | 41,349 (Direct) |
View |
| 2022-06-22 Option Award |
2022-06-24 08:10 am |
N/A 2032-06-22 |
Greenwich LifeSciences Inc. | GLSI | McWilliams David Director |
61,984 | $0 | 61,984 (Direct) |
View |